The arrhythmogenic N53I variant subtly changes the structure and dynamics in the calmodulin N-terminal domain,

Christian Holt1, Louise Hamborg1, Kelvin Lau2

  • 1Aalborg University, Department of Chemistry and Bioscience, 9220 Aalborg, Denmark.

Insights

Mutations in calmodulin (CaM) cause heart arrhythmias. The N53I CaM mutation, affecting the N-domain, alters interactions with the cardiac ryanodine receptor (RyR2), leading to arrhythmias.

Area of Science:

  • Molecular biology
  • Cardiovascular research
  • Protein dynamics

Background:

  • Calmodulin (CaM) mutations are linked to severe cardiac arrhythmias like catecholaminergic polymorphic ventricular tachycardia.
  • Most disease-causing mutations are in the C-terminal domain, but N53I is in the N-terminal domain and affects RyR2 regulation.

Purpose of the Study:

  • To investigate the molecular mechanism of the arrhythmogenic N53I CaM mutation.
  • To understand how N53I affects CaM's interaction with the cardiac ryanodine receptor (RyR2).

Main Methods:

  • Nuclear Magnetic Resonance (NMR) spectroscopy to study apo- and Ca2+-bound CaM-N53I structures and dynamics.
  • X-ray crystallography to determine the structures of wild-type (WT) and N53I CaM complexed with RyR2's calmodulin-binding domain (CaMBD2).

Main Results:

  • The N53I mutation does not significantly alter Ca2+ binding or overall CaM structure compared to WT CaM.
  • N53I substitution exposes a new hydrophobic surface and significantly alters intramolecular dynamics, destabilizing the CaM N-domain.
  • While N53I affects RyR2 regulation, it does not impact CaV1.2 channel regulation.

Conclusions:

  • The N53I mutation alters CaM's N-domain dynamics and its interaction with RyR2.
  • These altered interactions are the likely cause of the N53I-induced cardiac arrhythmia phenotype.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.5K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.7K
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
1.4K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
2.6K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.4K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
1.3K